• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Long-Term Safety and Efficacy of Esketamine in Patients With Treatment-Resistant Depression: A Review of Interim Results From the SUSTAIN-3 Trial

home / publications / supplement / long-term-safety-efficacy-esketamine-in-patients-treatment-resistant-depression-sustain-3-trial
© 2024 MJH Life Sciences
AJMC®
All rights reserved.